  This paper proposes data mining techniques to model the return on investment
from various types of promotional spending to market a drug and then uses the
model to draw conclusions on how the pharmaceutical industry might go about
allocating marketing expenditures in a more efficient manner, potentially
reducing costs to the consumer
